OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 11
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study
Mozhgan Hosseini-Ashrafi, Tim H Clayton, Michelle Herring, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 6, pp. 578-583
Open Access | Times Cited: 9
Mozhgan Hosseini-Ashrafi, Tim H Clayton, Michelle Herring, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 6, pp. 578-583
Open Access | Times Cited: 9
A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
Mingyue Wang, Xing‐Hua Gao, Li Zhang
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 941-951
Open Access | Times Cited: 7
Mingyue Wang, Xing‐Hua Gao, Li Zhang
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 941-951
Open Access | Times Cited: 7
Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study
Lucia Caminiti, Francesca Galletta, Simone Foti Randazzese, et al.
Children (2024) Vol. 11, Iss. 2, pp. 170-170
Open Access | Times Cited: 5
Lucia Caminiti, Francesca Galletta, Simone Foti Randazzese, et al.
Children (2024) Vol. 11, Iss. 2, pp. 170-170
Open Access | Times Cited: 5
Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study
Francesca Galletta, L Rizzuti, Stefano Passanisi, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 64-64
Open Access
Francesca Galletta, L Rizzuti, Stefano Passanisi, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 64-64
Open Access
EASI 100 as a Therapeutic Target in Pediatric Atopic Dermatitis
Josias Teixeira, André Aparício‐Martins, Mariana Pedroso, et al.
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
Josias Teixeira, André Aparício‐Martins, Mariana Pedroso, et al.
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study
Giuseppina Caiazzo, Maddalena Napolitano, Maria Quaranta, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
Giuseppina Caiazzo, Maddalena Napolitano, Maria Quaranta, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
Medication-related perceptions of children and adolescents with severe asthma and moderate-to-severe atopic dermatitis: a non-interventional exploratory study
Markus Herzig, Maike vom Hove, Astrid Bertsche, et al.
Allergy Asthma and Clinical Immunology (2025) Vol. 21, Iss. 1
Open Access
Markus Herzig, Maike vom Hove, Astrid Bertsche, et al.
Allergy Asthma and Clinical Immunology (2025) Vol. 21, Iss. 1
Open Access
Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China
Yuyi Wang, Ruiling Jia, Hu Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Yuyi Wang, Ruiling Jia, Hu Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Real‐life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety
Eulàlia Baselga Torres, Marta Ivars, Carolina Prat, et al.
JEADV Clinical Practice (2025)
Open Access
Eulàlia Baselga Torres, Marta Ivars, Carolina Prat, et al.
JEADV Clinical Practice (2025)
Open Access
An updated reappraisal of dupilumab in children and adolescents with moderate–severe atopic dermatitis
Giorgio Ciprandi, Amelia Licari, Maria Angela Tosca, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 6
Closed Access | Times Cited: 2
Giorgio Ciprandi, Amelia Licari, Maria Angela Tosca, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 6
Closed Access | Times Cited: 2
Dupilumab Efficacy and Safety Assessment in the Treatment of Atopic Dermatitis in Pediatric Patients: A Systematic Review
Valeria Antoniou, Elena Thomaidou, Ekatherine Prokopiou
Dermatological Reviews (2024) Vol. 5, Iss. 6
Closed Access
Valeria Antoniou, Elena Thomaidou, Ekatherine Prokopiou
Dermatological Reviews (2024) Vol. 5, Iss. 6
Closed Access
Real-world efficacy and safety of dupilumab for paediatric atopic dermatitis: a multicentre retrospective study
Eitan Pirov, Vered Molho‐Pessach, Eran Cohen‐Barak, et al.
Clinical and Experimental Dermatology (2024)
Closed Access
Eitan Pirov, Vered Molho‐Pessach, Eran Cohen‐Barak, et al.
Clinical and Experimental Dermatology (2024)
Closed Access
